JP2023507774A5 - - Google Patents
Info
- Publication number
- JP2023507774A5 JP2023507774A5 JP2022538083A JP2022538083A JP2023507774A5 JP 2023507774 A5 JP2023507774 A5 JP 2023507774A5 JP 2022538083 A JP2022538083 A JP 2022538083A JP 2022538083 A JP2022538083 A JP 2022538083A JP 2023507774 A5 JP2023507774 A5 JP 2023507774A5
- Authority
- JP
- Japan
- Prior art keywords
- fluoro
- thiadiazolidine
- trione
- hydroxy
- naphthalene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025159693A JP2026004380A (ja) | 2019-12-18 | 2025-09-26 | タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962949613P | 2019-12-18 | 2019-12-18 | |
| US62/949,613 | 2019-12-18 | ||
| PCT/US2020/066104 WO2021127499A1 (en) | 2019-12-18 | 2020-12-18 | Protein tyrosine phosphatase inhibitors and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025159693A Division JP2026004380A (ja) | 2019-12-18 | 2025-09-26 | タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023507774A JP2023507774A (ja) | 2023-02-27 |
| JP2023507774A5 true JP2023507774A5 (enExample) | 2023-12-20 |
| JP7751582B2 JP7751582B2 (ja) | 2025-10-08 |
Family
ID=74195125
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538083A Active JP7751582B2 (ja) | 2019-12-18 | 2020-12-18 | タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法 |
| JP2025159693A Pending JP2026004380A (ja) | 2019-12-18 | 2025-09-26 | タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025159693A Pending JP2026004380A (ja) | 2019-12-18 | 2025-09-26 | タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230019236A1 (enExample) |
| EP (1) | EP4077291A1 (enExample) |
| JP (2) | JP7751582B2 (enExample) |
| CN (1) | CN116348455A (enExample) |
| AU (1) | AU2020407648A1 (enExample) |
| CA (1) | CA3162069A1 (enExample) |
| MX (2) | MX2022007441A (enExample) |
| WO (1) | WO2021127499A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3908272B1 (en) | 2019-01-09 | 2023-03-22 | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. | L-triiodothyronine (t3) for use in limiting microvascular obstruction |
| AU2020401376A1 (en) | 2019-12-12 | 2022-06-30 | Kumquat Biosciences Inc. | Compositions and methods for potentiating immune activity |
| CN118556055A (zh) * | 2021-11-11 | 2024-08-27 | 卡里科生命科学有限责任公司 | 蛋白酪氨酸磷酸酶抑制剂及其使用方法 |
| MX2024005658A (es) * | 2021-11-11 | 2024-08-06 | Calico Life Sciences Llc | Inhibidores de proteina tirosina fosfatasa y metodos de uso de estos. |
| JP2025530135A (ja) * | 2022-09-13 | 2025-09-11 | カムクワット バイオサイエンシーズ インコーポレイテッド | ベンゾ縮合ｎ－複素環及びその使用 |
| WO2024243441A1 (en) | 2023-05-24 | 2024-11-28 | Kumquat Biosciences Inc. | Heterocyclic compounds and uses thereof |
| TW202519514A (zh) | 2023-07-14 | 2025-05-16 | 天主教魯汶大學 | 新穎化合物(一) |
| CN119818693A (zh) * | 2023-10-13 | 2025-04-15 | 华东师范大学 | 一种用于前药给药系统的可裂解支链连接体化合物及其制备和应用 |
| CN121627562A (zh) * | 2024-09-04 | 2026-03-10 | 南京圣和药业股份有限公司 | 作为wrn抑制剂的化合物及其应用 |
| WO2026112350A1 (en) * | 2024-11-22 | 2026-05-28 | Kumquat Biosciences Inc. | Heterocyclic compounds and uses thereof |
| WO2026132150A1 (en) | 2024-12-19 | 2026-06-25 | Katholieke Universiteit Leuven | Inhibitors of ptpn 2/ ptpn1 tyrosine phosphatase |
| WO2026132146A1 (en) | 2024-12-19 | 2026-06-25 | Katholieke Universiteit Leuven | Inhibitors of ptpn 2/ ptpn1 tyrosine phosphatase |
| WO2026132149A1 (en) | 2024-12-19 | 2026-06-25 | Katholieke Universiteit Leuven | Inhibitors of ptpn2 and/or ptpn1 |
| WO2026132148A1 (en) | 2024-12-19 | 2026-06-25 | Katholieke Universiteit Leuven | Inhibitors of ptpn2/ptpn1 tyrosine phosphatase |
| WO2026130528A1 (zh) * | 2024-12-20 | 2026-06-25 | 杭州百新生物医药科技有限公司 | Ptpn2/ptpn1抑制剂及其制备方法和医药用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5212A (en) | 1847-07-31 | Richard m | ||
| US162A (en) | 1837-04-17 | Island | ||
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| DK0495421T3 (da) | 1991-01-15 | 1996-12-09 | Alcon Lab Inc | Anvendelse af carragenaner i topiske ophthalmiske sammensætninger |
| UA94921C2 (en) * | 2005-12-08 | 2011-06-25 | Новартис Аг | 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors |
| TWI888352B (zh) * | 2018-06-21 | 2025-07-01 | 美商嘉來克生命科學有限責任公司 | 蛋白質酪胺酸磷酸酯酶抑制劑及其使用方法 |
| KR102983496B1 (ko) * | 2019-03-14 | 2026-06-29 | 칼리코 라이프 사이언시스 엘엘씨 | 단백질 티로신 포스파타제 억제제 및 이의 사용 방법 |
-
2020
- 2020-12-18 MX MX2022007441A patent/MX2022007441A/es unknown
- 2020-12-18 CA CA3162069A patent/CA3162069A1/en active Pending
- 2020-12-18 EP EP20845275.5A patent/EP4077291A1/en active Pending
- 2020-12-18 WO PCT/US2020/066104 patent/WO2021127499A1/en not_active Ceased
- 2020-12-18 AU AU2020407648A patent/AU2020407648A1/en active Pending
- 2020-12-18 CN CN202080097033.6A patent/CN116348455A/zh active Pending
- 2020-12-18 JP JP2022538083A patent/JP7751582B2/ja active Active
-
2022
- 2022-06-16 MX MX2026004270A patent/MX2026004270A/es unknown
- 2022-06-16 US US17/807,292 patent/US20230019236A1/en active Pending
-
2025
- 2025-09-26 JP JP2025159693A patent/JP2026004380A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530443A5 (enExample) | ||
| JP6640390B2 (ja) | 治療活性化合物及びその使用 | |
| JP6529492B2 (ja) | 癌の処置のためのｉｄｈ２突然変異体阻害剤としての２，４−または４，６−ジアミノピリミジン化合物 | |
| JP6409081B2 (ja) | 治療活性化合物およびその使用方法 | |
| JP5311673B2 (ja) | Ｍｅｋ阻害剤の使用方法 | |
| JP6648116B2 (ja) | 変異イソクエン酸デヒドロゲナーゼ阻害剤としてのキノリノンピリミジン組成物 | |
| IL305077A (en) | A quinazoline compound for inducing degradation of the G12D mutant cras protein | |
| JP2014521696A (ja) | セリン／スレオニンキナーゼインヒビターとしてのキナゾリン化合物 | |
| JP6490067B2 (ja) | 治療活性化合物およびその使用方法 | |
| KR102379517B1 (ko) | 세린/트레오닌 키나아제 억제제 | |
| EA023420B1 (ru) | Замещенные имидазопиридазины | |
| JP2010513288A5 (enExample) | ||
| JP2021530443A (ja) | タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法 | |
| CN105980387A (zh) | 丝氨酸/苏氨酸激酶抑制剂 | |
| RU2010102992A (ru) | Лиганды каннабиноидных рецепторов | |
| CN103539777A (zh) | Pi3激酶调节剂及其使用方法和用途 | |
| TW202206422A (zh) | 用於ｃｄ７３調節之化合物及方法及其適應症 | |
| TW202237119A (zh) | Ａｌｋ﹘５抑制劑和彼之用途 | |
| JP2026035660A (ja) | エキサテカン由来トポイソメラーゼ－１阻害薬医薬組成物及びその使用 | |
| JP2025506772A (ja) | ポロ様キナーゼ４（ｐｌｋ４）阻害剤、医薬組成物、ならびにそれらを調製する方法、及びそれらの使用方法 | |
| JPS63280082A (ja) | １，３‐ジオキサンアルカノイツク酸誘導体、その製法、これを含有する心臓及び血管の疾病の治療剤及び中間体 | |
| EP0329360A2 (en) | Pyridine derivatives | |
| RU2021101041A (ru) | Ингибиторы протеин-тирозинфосфатазы и способы их применения | |
| RU2023116996A (ru) | Ингибиторы протеин-тирозинфосфатазы и способы их применения | |
| RU2025103751A (ru) | Соединения на основе имидазопиридина, их получение и варианты их терапевтического применения |